Murine model of cancer gene therapy

  • Authors:
    • H Yi
    • I Nakashima
    • K Isobe
  • View Affiliations

  • Published online on: July 1, 1996     https://doi.org/10.3892/ijo.9.1.89
  • Pages: 89-93
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In order to examine how the adenovirus-mediated gene therapy induce anti-adenoviral immunity, we set up experiments for a murine cancer model. We first administered adenovirus carrying LacZ (AxCALacZ) gene to DBA/2 mice intraperitoneally, then two weeks after administration of the virus, P815 tumor cells infected with adenovirus carrying LacZ gene were inoculated intraperitoneally to the AxCALacZ immune mice. The mice rejected the P815 tumor infected with AxCALacZ and survived for long periods. The peritoneal T cells in adenovirus immune mice had a strong killing effect of adenovirus-infected P815 cells. Further, parental P815 tumor cells were inoculated into the mice, which rejected the P815 tumor infected with AxCALacZ. All mice rejected P815 tumor cells and survived for long periods. These mice developed P815 specific tumor immunity, which was confirmed by a cytotoxicity assay.

Related Articles

Journal Cover

July 1996
Volume 9 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yi H, Nakashima I and Isobe K: Murine model of cancer gene therapy. Int J Oncol 9: 89-93, 1996
APA
Yi, H., Nakashima, I., & Isobe, K. (1996). Murine model of cancer gene therapy. International Journal of Oncology, 9, 89-93. https://doi.org/10.3892/ijo.9.1.89
MLA
Yi, H., Nakashima, I., Isobe, K."Murine model of cancer gene therapy". International Journal of Oncology 9.1 (1996): 89-93.
Chicago
Yi, H., Nakashima, I., Isobe, K."Murine model of cancer gene therapy". International Journal of Oncology 9, no. 1 (1996): 89-93. https://doi.org/10.3892/ijo.9.1.89